NCT04322214View on ClinicalTrials.gov

Clinical Trial to Evaluate Pharmacological Interactions Between γ-hydroxybutyrate (GHB) and Cobicistat

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

January 30, 2020

Primary Completion Date

March 30, 2020

Study Completion Date

April 30, 2020

Conditions
Pharmacokinetic InteractionsHIV
Interventions
DRUG

Cobicistat 150 MG

once daily cobicistat (150 mg QD) for 5 days

DRUG

Placebo

once daily lactose capsules (as aspect cobicistat capsules)

DRUG

GHB

single oral dose of GHB (25 mg/kg) on days 5 and 17

Trial Locations (1)

08916

José, Badalona

All Listed Sponsors
lead

Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia

OTHER

NCT04322214 - Clinical Trial to Evaluate Pharmacological Interactions Between γ-hydroxybutyrate (GHB) and Cobicistat | Biotech Hunter | Biotech Hunter